Increased maternal morbidity observed in pregnant women with hematologic malignancy, reports research Jacinthlyn Sylvia16 Oct 2024 8:00 PM ISTA new study published in The Lancet Haematology showed that pregnant women with hematologic malignancies were more likely to experience severe...
Hydroxyurea dose escalation enhances clinical outcomes in children with sickle cell anemia: Study Jacinthlyn Sylvia5 May 2024 10:15 PM ISTThe Realizing Effectiveness Across Continents with Hydroxyurea (REACH) trial unveiled promising results in the treatment of sickle cell anemia among...
Ferric derisomaltose plus tranexamic acid may reduce blood transfusion risk by 50% in hip surgery Dr. Kamal Kant Kohli9 Sept 2023 9:00 AM ISTHip fractures are a common and serious injury, particularly among the elderly, often requiring surgery. Anaemia and the subsequent need for blood...
Prehospital transfusion not superior to 0.9 percent sodium chloride for trauma-related haemorrhagic shock: Lancet Medha Baranwal11 March 2022 9:00 AM ISTUK: Findings from a phase 3 trial showed that prehospital packed red blood cells (PRBC)-lyophilized plasma (LyoPlas) resuscitation is not superior to...
Low-dose hydroxyurea therapy may prevent stroke in children with sickle-cell anemia: Lancet Medical Dialogues Editorial Team21 Jan 2022 9:00 AM ISTKano, Nigeria: A new study found that as compared to low-dose hydroxyurea therapy, moderate-dose hydroxyurea therapy showed no change in stroke...
Early switch from heparin to dabigatran effective and safe for acute intermediate-risk PE: Lancet Dr. Shravani Dali20 Sept 2021 9:15 AM ISTAn early switch from heparin to dabigatran for acute intermediate-risk pulmonary embolism (PE) is both effective and safe, suggests a study...
